Another contradictory finding was reported in an epigenetics study, in which the cervical cancer group showed significantly higher CDKN2A methylation than the control group [29], suggesting a low CDKN2A expression level in cervical cancer. The gene discussed is CDKN2A; the disease is cervical carcinoma.